biguanides has been researched along with Encephalopathy, Hepatic in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walter-Sack, I | 1 |
| Berger, W | 1 |
1 review available for biguanides and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Reduction and delay in resorption as a pathogenetic and therapeutic principle].
Topics: Biguanides; Bile Acids and Salts; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Dietary Protei | 1979 |
1 other study available for biguanides and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Lactic acidosis (author's transl)].
Topics: Acidosis; Alcoholic Intoxication; Bicarbonates; Biguanides; Diabetes Complications; Fructose; Hepati | 1978 |